To ensure you recieve your Boston.com e-mails, please add newsletters@boston.com to your address book. | |||
| |||
Fri. Jan. 27, 2012 Siemens buys Cambridge Water TechnologySiemens AG has signed an agreement to acquire Cambridge Water Technology, based in Cambridge. The acquisition will be added to Siemens’ product portfolio of technologies for advanced water and wastewater treatment. | |||
UberVU powers new social media management platformA Cambridge company that builds tools to measure social media, uberVU, is powering a new social media management platform by NM Incite, a Nielsen/McKinsey Company. UberVU moved to Cambridge from London in November, 2011. | |||
Putnam Investments expands retirement sales teamPutnam Investments is expanding its sales team in an effort to meet anticipated demand from 401(k) sponsors and their advisors. Steven McKay, from Hartford Retirement Services, and Joseph Kaplan, previously with ADP Retirement Services, are both joining the company. Additional hires are expected in the sales and service areas in the months ahead. | |||
First Commons Bank assets top $168 million during tenth quarter of operationsFirst Commons Bank of Newton, Mass., today reported that its assets have grown to more than $168 million during its tenth quarter of operations, which ended December 31,2011. The bank began operations on July 22, 2009, and serves businesses and individuals in Newton, Wellesley, Waltham, and eastern Massachusetts. | |||
Goodwin Procter names Insolia managing partnerThe law firm Goodwin Procter has named Robert S. Insolia managing partner, the first to be based in New York City. Regina M. Pisa, who has served as both Chairman and Managing Partner of the law firm since 1998, will continue to serve as Chairman. Insolia joined Goodwin in 1997 as a founding partner of Goodwin’s New York office, which he chaired through 2004. | |||
DirecTV, Sunbeam reach agreementSunbeam Television, which owns WHDH-TV (Channel 7) and WLVI-TV (Channel 56), and satellite provider DirecTV have reached an agreement last night over retransmission fees. | |||
Airlines add more flights between Boston, Indianapolis over Super Bowl weekendSeveral airlines have added flights between Boston and Indianapolis over Super Bowl weekend, including several that don’t normal fly the route nonstop. | |||
Staples plans e-commerce innovation center in CambridgeStaples, the Framingham office products company, is ramping up a new “E-Commerce Innovation Center” in Kendall Square in Cambridge. Scheduled to open in May, 2012, the center will house teams responsible for designing and implementing innovative e-commerce solutions for customers who shop Staples stores and websites. The world’s second largest e-commerce company, behind Amazon, Staples is adding IT, product management, usability, and creative positions so it can better reach customers across mobile devices, desktops and stores, the company said. | |||
Massachusetts Life Sciences Center awards $5 million to Museum of ScienceThe Museum of Science, Boston will begin construction of a new exhibit, the Hall of Human Life, after receiving a $5 million grant from the Massachusetts Life Sciences Center. The Hall of Human Life, which is now scheduled to open in July 2013, will aim to revolutionize how people understand their own biology and manage their health, the Museum said in a release. | |||
Comcast launches “Hire a Veteran” serviceComcast Corporation today launched “Hire A Veteran On Demand,” which aims to connect returning soldiers to jobs to help ease their transition back into civilian life. The pilot program, which posts video profiles of returning soldiers who are looking for work, will be available for the next 90 days for prospective hiring managers and recruiters to review for their employment needs. | |||
Avila Therapeutics of Bedford to be bought by Celgene in a deal that could be worth $925mBedford drug developer Avila Therapeutics Inc. this morning said it has agreed to be acquired by biopharmaceutical giant Celgene Corp., based in Summit, NJ., in a buy-out deal potentially worth $925 million if Avila is able to eventually win approval to market treatments for cancer and other diseases. Avila, a five-year-old privately held biotechnology company backed by Waltham’s Polaris Venture Partners, specializes in covalent drug chemistry, which allows molecules to bind to disease proteins and shut them down. |
Friday, January 27, 2012
Daily Business Update
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment